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Transient ischemic attack (TIA) is deﬁned as focal neuro-
logical deﬁcit caused by ischemia resolving within
24 hours. In a secondary analysis of a large monocentric
cohort of 446 TIA patients, we explored the frequency
and determinants of diffusion-weighted imaging (DWI)
lesions on high-resolution magnetic resonance imaging.
Overall, 240 (54%) of all TIA patients presented with
DWI lesions. These patients had higher National Insti-
tute of Health Stroke Scale and ABCD2 scores and pres-
ented more frequently with vessel occlusion and
perfusion deﬁcits, but had similar functional outcome at
3 months. Taken together, high-resolution DWI provides
evidence of ischemic brain injury in the majority of TIA
patients.
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Traditionally and by the World Health Organization(WHO), a transient ischemic attack (TIA) has been
deﬁned as focal neurological deﬁcit caused by ischemia
lasting <24 hours. With the advent of diffusion-weighted
imaging (DWI), a new tissue-based deﬁnition has been
proposed by the American Heart Association/American
Stroke Association.1,2
DWI allows for an early sensitive diagnosis of ische-
mic injury.3 An increase of spatial resolution (high-
resolution DWI [hrDWI]) has been shown to improve
diagnostic accuracy.4 A systematic review found a pooled
proportion of 34% DWI lesions in TIA patients.5
Although the vast majority of DWI lesions turn into
T2-visible infarctions,6 animal studies show neuronal dam-
age may emerge even in the absence of imaging ﬁndings.7
Here, we studied the proportion of time-deﬁned
TIAs showing lesions on hrDWI, expecting a signiﬁcantly
higher rate than previously reported. In addition, we
hypothesized DWI lesions to be associated with (1) an
occlusion of the corresponding artery on magnetic reso-
nance angiogram (MRA), (2) a perfusion deﬁcit, (3) a
higher National Institute of Health Stroke Scale (NIHSS)
score at admission, (4) a higher risk for recurrent events as
measured by the ABCD2 score, and/or (5) worse func-
tional outcome (higher modiﬁed Rankin Scale [mRS]
score) at 3 months.
Patients and Methods
Patient Selection and Imaging
We performed an a priori deﬁned secondary analysis of
the 1000Plus observational cohort (clinicaltrials.gov
NCT00715533), which was reviewed by our institu-
tional ethics committee. A detailed protocol was publi-
shed previously.8 Brieﬂy, consecutive adult patients
presenting within 24 hours of a suspected cerebrovascu-
lar event between September 2008 and June 2013 were
included if they or their legal representative had provided
informed consent. Magnetic resonance imaging (MRI)
was performed as primary imaging during daytime, or in
addition to acute computed tomographic scans the next
morning if patients presented after regular hours (ie,
“admission MRI”). If admitted to the stroke unit,
patients received an early (next day) and late (after 4–6
days) follow-up MRI. Demographics and clinical data
were prospectively recorded, and all discharge letters were
reviewed for ﬁnal diagnosis. We included all patients ful-
ﬁlling the WHO criteria for TIA (with a complete clini-
cal remission within 24 hours) in this analysis. Patients
who received recanalization treatment were considered to
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have had ischemic strokes, irrespective of symptom dura-
tion, and therefore excluded. All MRI examinations were
performed on a Magnetom Trio (Siemens, Erlangen,
Germany). Imaging and postprocessing parameters on
hrDWI, time-of-ﬂight MRA, ﬂuid-attenuated inversion
recovery (FLAIR), T2*, and perfusion imaging were
reported previously.8
Statistical Analysis
Standard descriptive statistics were used for variance of
variables. An independent-samples Student t test or
Mann–Whitney U test was used to analyze differences in
scalar and nonparametric parameters, respectively, between
groups separated based on DWI lesions. Fisher’s exact test
was used for Boolean variables. Alpha level was set
at 0.05.
Results
We identiﬁed 446 patients presenting with a TIA
according to the time-based WHO deﬁnition within the
1000Plus dataset of 1,472 patients (Fig 1). Mean age was
68 years (standard deviation [SD] = 13), and 190 patients
were female (42.6%). Median NIHSS score at presenta-
tion was 0 (interquartile range [IQR] = 0–1). Further
baseline characteristics, risk factors, and outcome parame-
ters are presented in the Table.
A total of 240 patients (53.8%) had a DWI lesion
on baseline and/or follow-up MRI, of which 231 (51.8%)
were visible at admission. Perfusion deﬁcits were present
in 135 (35.2%) at any timepoint, and a corresponding
vessel occlusion was present in 72 (16.1%) patients.
Moreover, the lesion pattern (lacunar, territorial, etc), ves-
sel territory, or hemispheric distribution did not differ
between TIA and ischemic stroke patients (n = 773) in
the 1000Plus dataset (Supplementary Table 1).
In comparison, no DWI lesion was identiﬁed in
206 TIA patients (46.2%), who had a mean age of
67.8 years (SD = 13.1) and median NIHSS score of 0 at
presentation (IQR = 0–1). Perfusion deﬁcits were present
in 18.1%; a corresponding vessel occlusion was found in
6.8% (see also the Table). There was no signiﬁcant differ-
ence between the 2 differently deﬁned TIA cohorts in
terms of other vascular MRI markers such as number of
microbleeds on T2* or extent of vascular leu-
koencephalopathy on FLAIR.
In addition, we analyzed several predeﬁned clinical
and radiological characteristics for association with DWI
lesions. Occlusion of the corresponding vessel and perfu-
sion deﬁcit were strongly associated (odds ratio
[OR] = 4.37, 95% conﬁdence interval [CI] = 2.36–8.11
and OR = 4.06, 95% CI = 2.51–6.56, respectively) with
presence of DWI lesions, as was the volume of perfusion
deﬁcit (p = 0.005). In addition, admission NIHSS score
was associated with DWI lesions (p = 0.024); however,
functional outcome measured by mRS at 3 months was
not. Patients with DWI lesions had signiﬁcantly higher
ABCD2 scores (p = 0.002). For an overview of clinical
score distribution, refer to Figure 2.
Discussion
The main ﬁnding of this study is that the majority (ie, 54%)
of TIA patients have DWI lesions as measured by high-
resolution MRI, which is signiﬁcantly higher than in previ-
ous reports.5 Perfusion deﬁcits and occlusion of the
corresponding artery showed a robust association with DWI
lesions. NIHSS score at presentation predicted presence of
DWI lesions on imaging, as previously described.9 Although
previous reports described an association of DWI lesion in
TIA to symptom duration, we could not reproduce this
ﬁnding.10 However, patients with DWI lesions did present
signiﬁcantly sooner after the event. By design, we cannot
comment on the rate of reversible DWI lesions in the
patients without DWI pathology on the admission MRI.
Functional outcome was not different between TIA
patients with and without DWI lesions, suggesting an
overall similar midterm prognosis of the acute event.
FIGURE 1: Study ﬂow chart. From 1,472 patients in the
1000Plus cohort, 446 matched the inclusion criteria for this
analysis: suffering from transient cerebral ischemia lasting
<24 hours. Of these, 206 matched the newer deﬁnition
criteria of missing proof of tissue infarction by high-
resolution diffusion-weighted imaging. AHA = American
Heart Association; ASA = American Stroke Association;
ICH = intracerebral hemorrhage; MRI = magnetic resonance
imaging; N/A = no detailed data due to withdrawn consent;
SVT = sinus or deep vein thrombosis; TIA = transient
ischemic attack; WHO = World Health Organization.
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TABLE. Overview of the cohort’s baseline characteristics, risk factors and outcome parameters
time-based TIA
total DWI- DWI+ P OR/Method
n 446 (100) 206 (46.2) 240 (53.8)
Sex, n (%) female 190 (42.6) 105 (51.0) 85 (35.4) 0.001 0.53 (0.36-0.77)
Age, years 68.0  12.8 67.8  13.1 68.2  12.6 0.793 t-test
pre-stroke mRS 0 (0-0) 0 (0-0) 0 (0-0) MWU
Risk Factors, n (%)
Hyperlipoproteinemia 261 (58.7) 133 (64.6) 128 (53.3) 0.016 0.62 (0.42-0.91)
Diabetes mellitus 80 (18.0) 38 (18.5) 42 (17.5) 0.805 0.93 (0.57-1.51)
Arterial Hypertension 329 (73.9) 145 (70.7) 184 (76.7) 0.161 1.36 (0.89-2.08)
previous Stroke 121 (27.2) 44 (21.5) 77 (32.1) 0.014 1.73 (1.13-2.66)
previous TIA 55 (12.4) 37 (18.0) 18 (7.5) 0.001 0.37 (0.20-0.67)
Atrial Fibrillation 65 (14.6) 24 (11.7) 41 (17.1) 0.138 1.55 (0.90-2.67)
Admission NIHSS 0 (0-1) 0 (0-1) 0 (0-1) 0.024 MWU
Clinical Syndrome ABCD2, n (%) <0.001 MWU
Unilateral Weakness 192 (43.0) 65 (38.3) 127 (52.9)
Speech disturbance 115 (25.8) 62 (30.1) 53 (22.1)
Other 139 (31.2) 79 (38.3) 60 (25.0)
Duration of symptoms, n (%) 0.213 MWU
<10 minutes 77 (17.3) 38 (18.4) 39 (16.3)
10-60 minutes 103 (23.1) 52 (25.2) 51 (21.3)
>60 minutes 266 (59.6) 116 (56.3) 150 (62.5)
ABCD2 Score 4 (3-5) 4 (3-5) 5 (3.25-6) 0.002 MWU
mRS at discharge 0 (0-0) 0 (0-0) 0 (0-1) 0.329 MWU
mRS at 3 months 0 (0-1) 0 (0-1) 0 (0-1) 0.533 MWU
0 227 (63.1) 106 (65.0) 121 (61.4)
1 70 (19.4) 28 (17.2) 42 (21.3)
2 26 (7.2) 14 (8.6) 12 (6.1)
3 13 (3.6) 6 (3.7) 7 (3.6)
4 18 (5.0) 7 (4.3) 11 (5.6)
5 2 (0.6) 1 (0.6) 1 (0.5)
6 4 (1.1) 1 (0.6) 3 (1.5)
Delay ACS to imaging, minutes 775  421 855  411 706  418 0.001 t-test
DWI lesion in hospital stay, n (%) 240 (53.8) 0 (0) 240 (100) —
DWI lesion admission MRI 231 (51.8) 0 (0) 231 (96.3) —
DWI lesion early follow up MRIa 198 (80.2) 0 (0) 198 (96.1) —
DWI lesion late follow up MRIa 104 (94.5) 0 (0) 104 (98.1) —
DWI lesion vol at admission, ml 1.5  4.1 — 1.5  4.1 —
DWI lesion vol next day, ml 2.2  8.9 — 2.2  8.9 —
DWI lesion vol at follow-up, ml 2.0  4.7 — 2.0  4.7 —
Perfusion deﬁcit at admission, n (%) 135 (35.2) 29 (18.1) 106 (47.3) <0.001 4.06 (2.51-6.56)
Perfusion deﬁcit volume, ml 40.8 74.3 44.9  43.3 40.4  77.2 0.005 MWU
relevant MRA pathology, n (%) 72 (16.1) 14 (6.8) 58 (24.2) <0.001 4.37 (2.36-8.11)
Wahlund-Score 6 (3-9) 6 (3-9) 6 (4-9) 0.696 MWU
Microbleeds on T2*, n (%) 0.248 MWU
none 365 (78.0) 168 (81.5) 197 (82.1) —
1-2 57 (12.8) 27 (13.1) 30 (12.5) —
3-10 19 (4.3) 8 (3.9) 11 (4.6) —
> 10 5 (4.9) 3 (1.5) 2 (0.8) —
Data presented as mean  SD or median (IQR), as appropriate, unless speciﬁed otherwise.
apercentage given relates to patients having received the speciﬁed MRI scan and not to the total cohort. p-values obtained by use of Fischer’s exact test
if not otherwise speciﬁed.
MWU = Mann-Whitney-U-Test; t-test = Student’s t-test; DWI = Diffusion weighted imaging; ACS = acute cerebrovascular syndrome; def. = deﬁnition;
vol = volume.
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FIGURE 2: Distribution of National Institute of Health Stroke Scale (NIHSS) score at admission (A), ABCD2 risk score (B), and
functional outcome (modiﬁed Rankin Scale [mRS]) at discharge (C) and after 3 months (D), dependent on tissue status. Black bars
indicate time-based/World Health Organization (WHO)-deﬁned transient ischemic attack (TIA). White bars indicate tissue-
based/American Heart Association/American Stroke Association–deﬁned TIA. Hatched bars indicate time-based/WHO-deﬁned
TIA with diffusion-weighted imaging (DWI) lesion.
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Importantly, however, it has been well documented that
patients suffering from transient ischemic events with
proof of infarction have a signiﬁcantly higher rate of recur-
ring events.11,12 Although they were reﬂected by higher
ABCD2 scores in the patients with DWI lesions, our
study protocol was not designed to either clinically or
radiologically assess recurring events, due to short-term
follow-up.
This cohort is the largest comprehensive study on
hrDWI and perfusion imaging in TIA. Apart from a few
smaller case series,13,14 it is the ﬁrst robust analysis of
multiparametric stroke MRI at 3T in TIA patients. Few
reports so far have studied perfusion imaging in
TIA.13,15,16 Previous reports frequently included patients
with MRI signiﬁcantly later than 24 hours after the
event,17,18 or included minor strokes in their analyses.17,19
We included patients with persisting deﬁcits at presenta-
tion, if their syndrome resolved within 24 hours of onset
to reﬂect the time-based deﬁnition of TIA.
Our study is limited by relatively high rates of loss
in follow-up. Although this weakens conclusions about
outcome, the cohort remains thoroughly characterized in
terms of the event and imaging characteristics. We cannot
completely rule out that early recurrent ischemia and not
the initial TIA caused DWI lesions on imaging, as espe-
cially patients with DWI lesions show a higher risk of
early recurring events.11,20 Given that of the 240 total
subjects presenting with DWI lesions, 231 already pres-
ented with it at initial MRI examination, however, we
consider this possible bias negligible. Patients with DWI
lesions presented signiﬁcantly later after the event, render-
ing reversible lesions in the DWI-negative group possible.
We found no reversible DWI lesions in the follow-up
scans of TIA patients with DWI lesions, and therefore
consider this possible bias negligible. Although the report
of lesions on DWI may have affected the diagnostic
workup and secondary prevention regime of the patients,
withholding that information from the treating physicians
would have been ethically unacceptable.
In conclusion, we found a higher incidence of ische-
mic lesions in TIA patients than previously reported when
using hrDWI. Differences in clinical severity corroborate
the tissue-based deﬁnition of TIA. hrDWI is a sensitive
surrogate marker, and may serve in clinical research for
improved secondary prevention. It furthermore guides
patient workup after ﬁrst ischemic event.
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